Stream Health, WPP’s “unconference” which took place in Florida earlier this week, provided a diverse and large amount of content in a short amount of time.
The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.
Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn’t MannKind set a firm launch date for the product?
Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.
Digital sage Richman returns to healthcare
July 17, 2014
8:15 pm
He started the Dose of Digital blog in 2008, then left healthcare. Now, after more than two years away, Jonathan Richman says he’s back in the business.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix